Abstract
The aim of this study was to analyze the utility of liver function tests (LFT) and fatty liver index (FLI), a surrogate marker of non-alcoholic fatty liver disease, in the categorization of metabolic phenotypes in a Mediterranean population. A cross-sectional study was performed on a random representative sample of 2233 adults assigned to a health center in Málaga, Spain. The metabolic phenotypes were determined based on body mass index (BMI) categorization and the presence or absence of two or more cardiometabolic abnormalities (high blood pressure, low high-density lipoprotein (HDL) cholesterol, hypertriglyceridemia, pre-diabetes) or type 2 diabetes. No difference was observed between metabolically healthy and metabolically abnormal phenotypes on LFT. The mean FLI of the population was 41.1 ± 28.6. FLI was significantly higher (p < 0.001) in the metabolically abnormal phenotypes in all BMI categories. The proportion of individuals with pathological FLI (≥60) was significantly higher in the metabolically abnormal overweight and obese phenotypes (p < 0.001). On a multivariate model adjusted for sex, age, and waist circumference, a significant correlation was found between pathological FLI and metabolically abnormal phenotypes in the overweight and obese BMI categories. Area under the curve (AUC) of FLI as a biomarker was 0.76, 0.74, and 0.72 for the metabolically abnormal normal-weight, overweight, and obese groups, respectively. Liver biochemistry is poorly correlated with metabolic phenotypes. Conversely, a good correlation between FLI, as a marker of non-alcoholic fatty liver disease (NAFLD), and metabolically abnormal phenotypes in all BMI ranges was found. Our study suggests that FLI may be a useful marker for characterizing metabolically abnormal phenotypes in individuals who are overweight or obese.
Highlights
The liver is the largest gland in the human body and plays a role in many functions, such as bile production as well as absorbing and metabolizing bilirubin, fats, proteins, and carbohydrates.Due to the obesity pandemic, non-alcoholic fatty liver disease (NAFLD) is currently the most commonInt
There is a well-established correlation between NAFLD and body mass index (BMI) and metabolic syndrome (MetS), metabolically discordant phenotypes have been described, with thin subjects who present with MetS and NAFLD and subjects with overweight or obesity who present with no metabolic complications or NAFLD
We found no significant differences on liver function tests (LFT) between metabolically healthy and metabolically abnormal individuals in any of the BMI categories
Summary
The aim of this study was to analyze the utility of liver function tests (LFT) and fatty liver index (FLI), a surrogate marker of non-alcoholic fatty liver disease, in the categorization of metabolic phenotypes in a Mediterranean population. The aim of this study was to analyze the utility of liver biochemistry and FLI in the categorization of the metabolic phenotypes in a Mediterranean population
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have